Working Up Donors for High-Urgency and Elective Adult-to-Adult Live Donor Liver Transplantation

Size: px
Start display at page:

Download "Working Up Donors for High-Urgency and Elective Adult-to-Adult Live Donor Liver Transplantation"

Transcription

1 LIVER TRANSPLANTATION 13: , 2007 ORIGINAL ARTICLE Working Up Donors for High-Urgency and Elective Adult-to-Adult Live Donor Liver Transplantation See Ching Chan, Sheung Tat Fan,* Chi Leung Liu, Chung Mau Lo, Banny K. Lam, and Evelyn W. Lee Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, China Donor workup for adult-to-adult live donor liver transplantation is done to ensure that the donor remains physically and psychologically healthy after saving or improving the life of the recipient. Even though two-thirds of the liver transplants in our center were from live donors, this life-saving procedure remains a mere treatment option, given the magnitude of the donor operation with the associated donor risks. Live donor liver transplantation was also adopted for high-urgency situations provided that the donor was suitable and the recipient considered salvageable. Donor workup in this setting had not been reported in the literature. In this cohort of 399 potential donors, 128 (32.1%) ultimately underwent donor surgery. Donors in the high-urgency situation had a lower operation rate of 28.4% (64/225) compared with that of 36.8% (64/174) of donors in the elective situation (P 0.049). Dropouts from step 1 mainly because of ABO incompatibility, positive hepatitis serology, comorbidities, and voluntary donor withdrawal were 52.6% (210/399). Only 11.6% (22/189) of the potential donors who proceeded to subsequent steps of the workup dropped out (2 were psychologically unsuitable, 10 were anatomically prohibitive). The transplantation rate of potential recipients with 1 or more potential donors was also high. The rates were similar for the high-urgency (55%, 64/116) and the elective (51%, 64/125) situations. In a region with scarcity of deceased donor liver grafts, careful and expeditious initial donor workup minimizes dropouts from subsequent steps and allows timely transplantation in high-urgency situations. Liver Transpl 13: , AASLD. Received April 6, 2006; accepted October 2, See Editorial on Page 478 Liver transplantation is an effective treatment for endstage liver disease of various etiologies and the best treatment for small, unresectable hepatocellular carcinoma. 1,2 In a decade s time, live donor liver transplantation (LDLT) has become a practical alternative to deceased donor liver transplantation (DDLT). This is attributable to the refractory shortage of deceased donor liver grafts, predictable recipient survivals, and acceptable donor morbidity and mortality. Nevertheless, the inevitable donor morbidity and mortality remain the major drawbacks of LDLT, as the donors undergo major surgery for the recipients and not for themselves. The donor s gain could be only psychological by saving and improving the life of the recipient. 3 This aspect remains the ethical challenge of LDLT. 4,5 Unanimously, the transplant community agreed upon the notion of safety first for the donor. 6 Such tenet could be realized only by providing the voluntary live liver donor with holistic care of the highest standard achievable as soon as the option of LDLT comes into the picture. In essence, the altruistic live liver donor should be protected from any harm in excess of the donor procedure itself, which is already a major operation for a healthy human being. The workup of the potential donor is no less a serious procedure as compared to the donor operation, as the workup itself could be conducive to profound impacts on the potential donor s psyche, decision, satisfaction, and certainly the outcome of the potential recipient. Abbreviations: LDLT, live donor liver transplantation; DDLT, deceased donor liver transplantation; ALDLT, adult-to-adult live donor liver transplantation. Supported by Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery. Address reprint requests to Prof. Sheung Tat Fan, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Rd., Hong Kong, China. Telephone: ; FAX: ; stfan@hku.hk DOI /lt Published online in Wiley InterScience ( American Association for the Study of Liver Diseases.

2 510 CHAN ET AL. Figure 1. Number and proportion of liver transplantations performed each year. Dots denote adult-to-adult DDLT. Diagonal lines denote pediatric DDLT. Vertical lines denote domino liver transplantation. White areas within bars denote ALDLT. Horizontal lines denote pediatric live donor liver transplantation. The donor workup has 3 main purposes. First, it is to ensure that the donor could undergo the donor operation with ethically acceptable and lowest possible morbidity and mortality. Second, it is to determine that a part of the donor s liver could be used reliably as a graft for the intended recipient. Third, with such knowledge, the benefit of LDLT over DDLT in each individual case in relation to the deceased donor liver graft availability and potential recipient urgency could be assessed. We aimed to analyze and report the experience of donor workup in our center, which has a case mix of LDLT and DDLT, and two-thirds of which belong to the former group (Fig. 1). Since 1989, LDLT has progressed from the setting of clinical trials to the standard mode of treatment. The manner in which the potential donor is worked up has evolved in parallel with the recipient and donor outcomes. In our center, LDLT has been practiced as a standard treatment through technical and logistic refinement since our first case in In contrast to the impetus of other centers, LDLT for recipients of high urgency was the main impetus for initiation of our program in the early 1990s. It has since become a standard practice code in our center. 7 This category of recipients includes those who are in acute, acute-onchronic, or in chronic liver failure and on life-support. High-urgency donors are those who are worked up for these recipients. The criteria for a high-urgency candidate were comparable to those for the United Network for Organ Sharing priority status 1 category. In this study, we focused on our experience in adult-to-adult LDLT (ALDLT). The reasons for declaring a potential donor unsuitable were analyzed. Such information may guide and expedite workup for future potential donors. Results were also compared with those of other series, taking into consideration the different practices of LDLT and availability of deceased donor liver grafts. PATIENTS AND METHODS Being a tertiary referral center, the Department of Surgery of the University of Hong Kong provides a liver transplant service covering the entire territory of Hong Kong, which has a population of 6.9 million, 95% of whom are Chinese. The first DDLT was performed on October 5, 1991, and the first adult-to-child LDLT was performed on September 28, The left liver was used in our initial experience of ALDLT, which could be dated back to July 12, The first right liver ALDLT was performed in our center on May 9, Prospective data collection for potential donors started in Jan-

3 WORKING UP DONORS 511 uary Therefore, cases from that date until December 2004 were included in this study. The annual case load of liver transplants rose to 76 in the year 2004, among which there was 1 domino liver transplant and 55 LDLTs (42 right liver and 5 left liver ALDLTs) (Fig. 1). For ALDLT, the right liver including the middle hepatic is the workhorse of our center. Potential recipients were managed by the surgical team in conjunction with the hepatologists. At the potential-recipient evaluation stage, the patient and the family members were introduced the salient information on liver transplantation. This information included an estimated recipient hospital mortality of 5% and a 5-year overall survival of 75-80%. The estimated donor mortality of 0.5-1% and a complication rate of 15-20% were also explained. These estimates were based on the reported series and our center s experience. We acknowledged that the long-term risks to the donor of the right liver and the left liver beyond 8 and 12 years respectively were not known. To reflect the experience of our center, the number of cases of LDLT performed up to the point of the case being worked up was made known to the potential recipients and potential donors. In our region, the deceased donor liver graft donation rate has been low and remained at an average of 3 liver grafts per million population per year. The possibility of LDLT, a legitimate and realistic alternative, was therefore explicitly explained to the potential recipients and potential donors. The deceased donor liver graft scarcity was responsible for a 50% mortality of potential recipients on the waiting list 9 and a 90% mortality for those who required life support. 7 Patients with hepatocellular carcinoma and who fulfill the listing criteria for DDLT in general have a 20% recurrence rate for LDLT. Once the indication for liver transplantation of the recipient was ascertained, the option of LDLT was raised again for the very reason of scarcity of deceased donor liver grafts and the high recipient mortality on waiting list. LDLT has been known to the public already as a result of wide media coverage in recent years. Hepatitis B was endemic and had a high carrier rate of 10% in our population. 10 Thus, the issue of introducing LDLT was often found to be unnecessary. Nevertheless, the option of ALDLT was introduced to those who had no prior knowledge of it. The issue of coercion of the donor is constantly avoided. The voluntary nature of the donation was therefore emphasized. When a potential donor identified himself or herself, donor evaluation proceeded in a stepwise fashion. Results of investigation were disclosed only to the potential donor directly by the transplant coordinator. Freedom of withdrawal was allowed at any stage of the donor workup. A medical reason could be provided by the medical staff on behalf of the potential donor. Potential donors were evaluated in sequence and not in a group to prevent coercion from the group itself. Blood tests would be performed simultaneously for multiple potential donors only in emergent LDLT and when the chance of rejection of the potential donor was high, as in the case of a hepatitis B carrier among siblings. The logistics of the donor workup is listed in Table 1. Step 1 TABLE 1. Synopsis of Workup Protocol For the Potential Live Liver Donor Step 1 Medical history: Diabetes, hypertension, ischemic heart disease, malignancy, peptic ulcer history, mental illness. Drug and allergy history. Contraceptive practice for female of reproductive age (pregnancy test if sexually active). Physical examination: Body weight, body height, blood pressure, heart, lung, and abdominal examination. Urinalysis. Hematology: Blood type and screen. Complete blood picture, international normalized ratio, activated prothrombin time. Biochemistry: Liver function test, gamma glutamyl transpeptidase, amylase, renal function test, random glucose. Serology: HBsAg, HBsAb, HBcAb, antihcv, HIV I/II, cytomegalovirus, varicella zoster virus. Step 2a Clinical psychological assessment. Step 2b Chest radiograph, electrocardiogram. Computed tomography of liver with bicarbonate cover. Volumetric analysis (right, left, & caudate lobe; and for pediatric recipients, left lateral segment). Maximum intensity projections of hepatic veins and portal veins. 3-dimenional reconstruction of hepatic artery. Step 3 Liver biopsy if signs of fatty liver from computed tomography. Visceral angiogram if computed tomography angiographic features not informative. Step 4 Informed consent of LDLT from donor and recipient. Minor consent from a relative of the potential donor with no direct interest from the recipient. Human leukocyte antigen typing. Cross match. Abbreviations: HBsAg, hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBcAb, hepatitis B core antibody; anti HCV, hepatitis C antibody; HIV, human immunodeficiency virus. A detailed medical and drug history is taken to identify any medical problem that may increase morbidity or mortality from donor hepatectomy. There is a consensus in the transplant community that donors are

4 512 CHAN ET AL. healthy subjects. 11 History of diabetes, hypertension, ischemic heart disease, malignancy within the last 5 years, and active mental disorders preclude the candidacy of donation. History of peptic ulcer disease mandates an upper endoscopy. Donation is also precluded in the presence of peptic ulcer. Allergic history is clarified. Female potential donors of reproductive age who are sexually active undergo a pregnancy test. The use of oral contraceptive pills indicates perioperative deep vein thrombosis prophylaxis by subcutaneous heparin in addition to physical means. A body mass index higher than 30 does not automatically preclude the potential donor, but it manifests a cautionary sign for fatty liver and underlying medical problems related to obesity. Blood group compatibility is verified. Hepatitis B surface antigen positivity and hepatitis C positivity preclude donation. The presence of antibody to hepatitis B core antigen represents previous exposure to hepatitis B virus but is not an absolute contraindication for donation. However, lifelong hepatitis B prophylaxis for the recipient by nucleoside analogue reverse transcriptase inhibitor is mandatory if the recipient is hepatic B surface antigen negative. Step 2a While the initial screen for the genuineness of the potential donor is done by the surgical team prior to any blood test, a more comprehensive, third-party psychological assessment is performed by a dedicated clinical psychologist. Such evaluation is feasible even at odd hours should the condition of the potential recipient demand an emergent ALDLT. Knowledge of the potential donor on ALDLT is verified. This knowledge includes conversance in donor and recipient morbidity and mortality, and the urgency of the recipient requiring the transplant. The potential donor s ability to cope with the major donor operation is assessed. In addition to psychological assessment, counseling and support are also provided. Step 2b Chest radiograph and electrocardiogram are obtained. Computed tomography with maximum intensity projections of the portal and hepatic veins is undertaken, and 3-dimensional reconstruction of the hepatic artery is performed under sodium bicarbonate cover. 12 Volumetry has been described elsewhere. 13 Attenuation of the liver parenchyma on the plain film is assessed for detection of fatty change. For ALDLT, the right liver is often used unless the donor is substantially heavier than the recipient. The right liver of the donor to the estimated standard liver volume less than 35% is associated with increased recipient mortality, 14 and thus donor candidacy will be cancelled. A contraindication exists if the right anterior portal vein arises from the left portal vein distal to the umbilical fissure. Presence of substantial inferior hepatic vein(s) allows anticipation during operation. Attention to the presence of segment 4b hepatic vein or segment 3 hepatic vein draining into the middle hepatic vein calls for a more caudal division of the middle hepatic vein to preserve adequate drainage of segment 4 of the remnant left liver. 13 Hepatic artery anatomy is best shown by the 3-dimensional reconstructions. The replaced right hepatic artery provides a long hepatic artery segment in the graft, but the aberrant position is also predisposed to premature severing in the donor procedure. The location of the segment 4 hepatic artery is also determined. Step 3 Suggestion of fatty change of the liver as detected by computed tomography mandates liver biopsy, which is to be done only after affirmation of suitability of the donor otherwise. A fatty change of up to 10% by histopathology is acceptable. Since case No. 140, visceral angiogram has been done only selectively if the 3-dimensional hepatic artery reconstruction does not provide enough details. Step 4 TABLE 2. Overall Outcomes of Donor Candidacy Informed consent including donor and recipient morbidity and mortality as spelled out will be obtained from the potential donor. A minor consent is obtained from a donor relative who has no direct benefit from the recipient s operation. Human leukocyte antigen typing and cross-match are then performed. RESULTS ALDLT Potential recipients 456 Potential recipients with potential 241 donors Potential donors 399 Ratio of potential donors to potential 399/456 (0.87) recipients Ratio of potential donors to potential 399/241 (1.66) recipients with at least one potential donor Live donor liver transplantation 128 (64/64) performed (high-urgency/elective) Potential donor dropouts 271 Dropouts of potential donors 271/399 (68%) NOTE: Value underlined indicates high-urgency. From January 2001 to December 2004, 137 ALDLTs were performed in our center. The left liver was used in 8 cases. Over this 3-year period, 399 potential donors were evaluated for a total of 456 potential recipients. The ratio of potential donors to potential recipients was 0.88 (399/456). Only half of the potential recipients had 1 or more potential donors (241/456; 52.9%). The ratio of potential donors to potential recipients with 1 or more potential donors was 1.66 (399/241). Dropout of potential donors was 68% (271/399) (Table 2). The po-

5 WORKING UP DONORS 513 TABLE 3. Potential Donor Characteristics and the Donor s Relationship With the Potential Recipient Potential Donor Characteristics ALDLT Potential donor 399 Gender (M/F) 165: 234 Age (yr)* 35 (18-61) Relation Parent 14 (3.5%) Grandparent 0 (0%) Spouse 103 (25.8%) Sibling 89 (22.3%) Offspring 133 (33.3%) 2 nd degree relative 34 (8.5%) 3 rd degree relative 7 (1.8%) Friend 19 (4.8%) *Values are expressed as median with range in parentheses. tential donor characteristics and their relationship with the potential recipients are listed in Table 3. The majority of potential donors were offspring (133/399; 33.3%) and spouses (103/399; 25.8%), followed by siblings (89/399; 22.3%). Workup was conducted in a stepwise fashion. Potential donors rejected in each step and their reasons for rejection are tabulated in Figure 2. Of the 399 potential donors, 210 (52.6%) dropped out in step 1. Among them, 144/395 were either ABO incompatible or hepatitis carriers and had other medical reasons, whereas 42 withdrew voluntarily. A total of 24 potential donors dropped out because there was another suitable potential donor simultaneously. Dropouts from step 2a onward were few. Only 2 potential donors were rejected following clinical psychological assessment. Of the 189 potential donors who proceeded to step 2b, 20 were rejected for reasons primarily due to liver anatomy. Inadequate size of the remnant left liver (n 5) and fatty change (n 7) were the main reasons for rejection. The lower limit for remnant left liver was 30%. 15 Inadequate size of the graft was an uncommon reason (1 potential donor; Fig. 2). because the right liver including the middle hepatic vein was used. A lower limit of 35% of the estimated standard liver mass was adopted. 14 Ultimately, 128 (32.1%) of these 399 potential donors were found suitable and underwent donor surgery. A total of 36 adults did not proceed to LDLT because of changes in conditions of the potential recipients. Details of these unaccomplished LDLTs are listed in Table 4. Among them, 13 adults were able to undergo DDLT. Complications During the Workup Period No complication occurred in the donors during the workup phase. Since June 2004, donors undergoing computed tomography have received bicarbonate cover and hydration to prevent contrast-induced nephropathy. 12 Visceral angiographies were performed only when 3-dimensional reconstruction of the hepatic arteries was not informative enough. No complication resulted from this invasive procedure in the minority of potential donors who underwent angiography. High Urgency vs. Elective LDLT Of the 456 adult potential recipients, 241 had 1 or more potential donors. These 241 potential recipients with potential donors had a transplantation rate of 58.5% (141/241). For these 141 transplants, 128 were ALD- LTs and 13 were DDLTs. The rate was slightly lower than that of our study reported previously in which the transplantation rate was 72% for potential recipients who had potential donors. 9 In 2000, only 9 DDLTs were performed (Fig. 1). Subgroup analysis showed that 64 (55%) of the 116 high-urgency adult potential recipients and 64 (51%) of the 125 elective adult potential recipients proceeded to ALDLT eventually (P 0.537). More potential recipients in the high-urgency situation dropped out because of potential recipient reasons (21 vs. 15) (Table 4). Among these 21 potential recipients, 8 underwent DDLT, reflecting the deceased donor graft allocation policy of transplanting the sickest. The ultimate donation (operation) rates of donors in high-urgency and elective ALDLT were 28.4% (64/225) and 36.8% (64/174), respectively (P 0.049). This lower potential donor operation rate in the high-urgency ALDLT was mirrored by the higher dropout rate of 71.6% (161/252) and when compared with that of 63.2% (110/174) in the elective situation. Potential donor dropouts were mainly a result of ABO incompatibility and comorbidities (Fig. 2). The time for commencement of donor workup to transplant operation was much shorter for high-urgency ADLT (0.33 [range, ] days vs. 24 [range, 2-453] days) (P 0.000). DISCUSSION All too frequently, the risks and potential harm that the potential donor faces overcast the benefit of LDLT of saving the potential donor s child, spouse, parent, and other beloved. Our data indicated that a high proportion of potential donors were subsequently determined suitable candidates and underwent the donor operation (32.1%). This finding was much in contrast with another series in which only 14% of the donors 16 and 17% of the recipients 17 actually proceeded to ALDLT surgery. The high rate of donors undergoing the operation in our study could be attributed to the fact that a substantial portion of the subjects had had blood tests already performed while considering for the donation. This fact particularly applies to those relatives of the potential recipients living in another region and coming to Hong Kong specifically for the donor operation. For female potential donors who had given birth to children, blood group and hepatitis status had already been known. Nevertheless, there was a slightly but sig-

6 514 CHAN ET AL. Figure 2. Reasons for dropout of potential donors. TABLE 4. Recipient Reasons For Adult-To-Adult Live Donor Liver Transplantation Not Accomplished Recipient condition uation was not actually performed by the surgeon, interpersonal reactions of the potential donor to the issue of LDLT were carefully appraised. The importance of the surgeon s experience in handling this issue was, however, hard to validate. Only 2 of the 189 potential donors were determined not suitable for psychological reasons, whereas 10 potential donors were found unsuitable due to anatomical reasons. Practically, apart from potential recipient reasons (n 36), the remaining potential donors proceeded to operation. Therefore, in the high-urgency situation, step 1 of donor workup is logistically crucial and should be accomplished expeditiously. Among the 20 potential donors who dropped out in step 2b, 7 were excluded due to fatty liver as revealed by computed tomography. Other centers have a routine 21 or a much lower threshold 22 for performing liver biopsy on potential donors. Our experience counts on screening with computed tomography of the liver. Liver biopsy is not performed on potential donors with moderate-to-severe fatty change as revealed by computed tomography. It is performed only to ascertain the degree of fatty change when anticipated to be mild. Furthermore, routine liver biopsy is not practical in high-urgency ALDLT. The degree of fatty change also varies throughout the liver; thus, the biopsy result is subjected to sampling error. Technical refinement of ALDLT both for the recipient and the donor circumvents a number of anatomical variations, rendering them contraindications no longer. Such refinement included venoplasty of the anterior and posterior branches of the right portal vein. 23 Hepatic vein venoplasty to provide reliable venous outflow without compromising remnant left liver venous drain- Highurgency Elective Uncontrolled sepsis Tumor progression Deceased donor liver transplantation Recipient declined LDLT Condition improved Neurological complication Uncontrolled gastrointestinal bleeding Multiple organ failure Intraoperative severe adhesions Myeloproliferative disease Respiratory failure Total nificantly lower ultimate donation rate of potential donors in high-urgency ALDLT. Under our current donor workup scheme, half of the dropouts (210/399, 52.5%) were determined in step 1. Beyond step 1, 128/189 (67.7%) potential donors eventually underwent ALDLT as donors. This percentage is higher than that of other series: 15/26 (57.7%), 18 46/89 (51.7%), 19 51/164 (31.1%). 20 The low wastage of our series could be ascribed to a number of factors. It could well be the result of screening already done by the surgeon even before step 1. Although a structured eval-

7 WORKING UP DONORS 515 age has been adopted. A low insertion of the segment 4b hepatic vein into the middle hepatic vein posed no major problem. 13 Seamless hepatic artery anastomosis under the operating microscope also gave reliable results regardless of the arterial configurations. 24 Safety margin of graft size has also been extended as a result of technical innovations and skill perfection. The minimal graft size has decreased from 40% 25 to 35%. 14 This experience may be applied only to the right liver graft including the middle hepatic vein. A significant portion of the recipients underwent high-urgency ALDLT. The time allowed for workup and evaluation of the donor was short, and in 1 case it took only 8 hours. There was much concern about donor coercion due to the pressing situation of the recipient s rapid deterioration. On the other hand, a gradually deteriorating recipient could as well be a constant source of uneasiness for the close family members, which arguably could be a source of pressure. Alternatively, donation from a distant relative could be more altruistic. The argument could go as far as the undirected donation from a Good Samaritan. In conclusion, the voluntary donor should undergo careful and expeditious workup. This workup should include provision of salient information about donor risks, possible harm, and recipient benefit. Even though a live donor will not benefit from the operation physically, the loss from failure to save the recipient can result in much psychological remorse. Based on the personal values of the donor and the recipient, they both should have a say. 26 Voluntarism should not be hampered by negativism from the transplant community. REFERENCES 1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334: Van Thiel DH, Colantoni A, De MN. Liver transplantation for hepatocellular carcinoma? Hepatogastroenterology 1998;45: Singer PA, Siegler M, Whitington PF, Lantos JD, Emond JC, Thistlethwaite JR, Broelsch CE. Ethics of liver transplantation with living donors. N Engl J Med 1989;321: Surman OS. The ethics of partial-liver donation. N Engl J Med 2002;346: Cronin DC, Millis JM, Siegler M. Transplantation of liver grafts from living donors into adults too much, too soon. N Engl J Med 2001;344: Surman OS, Hertl M. Liver donation: donor safety comes first. Lancet 2003;362: Liu CL, Fan ST, Lo CM, Wong J. Living-donor liver transplantation for high-urgency situations. Transplantation 2003;75(Suppl):S33 S Lo CM, Fan ST, Liu CL, Lo RJ, Lau GK, Wei WI, et al. Extending the limit on the size of adult recipient in living donor liver transplantation using extended right lobe graft. Transplantation 1997;63: Liu CL, Lam B, Lo CM, Fan ST. Impact of right-lobe live donor liver transplantation on patients waiting for liver transplantation. Liver Transpl 2003;9: Yuen MF, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 2004;41: Abecassis M, Adams M, Adams P, Arnold RM, Atkins CR, Barr ML, et al. Consensus statement on the live organ donor. JAMA 2000;284: Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291: Chan SC, Lo CM, Liu CL, Wong Y, Fan ST, Wong J. Tailoring donor hepatectomy per segment 4 venous drainage in right lobe live donor liver transplantation. Liver Transpl 2004;10: Fan ST, Lo CM, Liu CL, Yong BH, Wong J. Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation. Ann Surg 2003;238: Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135: Valentin-Gamazo C, Malago M, Karliova M, Lutz JT, Frilling A, Nadalin S, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl 2004;10: Rimola A, Llovet JM, Navasa M, Bruix J, Londono MC, Fuster J, Garcia-Valdecasas JC. Applicability of adult-toadult living donor liver transplantation. J Hepatol 2005; 43: Trotter JF, Wachs M, Trouillot T, Steinberg T, Bak T, Everson GT, Kam I. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000;6: Pascher A, Sauer IM, Walter M, Lopez-Haeninnen E, Theruvath T, Spinelli A, et al. Donor evaluation, donor risks, donor outcome, and donor quality of life in adultto-adult living donor liver transplantation. Liver Transpl 2002;8: Pomfret EA, Pomposelli JJ, Gordon FD, Erbay N, Lyn PL, Lewis WD, Jenkins RL. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 2003;76: Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000;6: Nadalin S, Malago M, Valentin-Gamazo C, Testa G, Baba HA, Liu C, et al. Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits. Liver Transpl 2005;11: Lee SG, Hwang S, Kim KH, Ahn CS, Park KM, Lee YJ, et al. Approach to anatomic variations of the graft portal vein in right lobe living-donor liver transplantation. Transplantation 2003;75(Suppl):S28 S Wei WI, Lam LK, Ng RW, Liu CL, Lo CM, Fan ST, Wong J. Microvascular reconstruction of the hepatic artery in live donor liver transplantation: experience across a decade. Arch Surg 2004;139: Lo CM, Fan ST, Liu CL, Chan JK, Lam BK, Lau GK, et al. Minimum graft size for successful living donor liver transplantation. Transplantation 1999;68: Spital A, Spital M. The ethics of liver transplantation from a living donor. N Engl J Med 1990;322:

One of the most important problems for patients

One of the most important problems for patients Selection of Donors and Recipients for Living Donor Liver Transplantation Key Points 1. Living donor liver transplantation (LDLT) is increasingly used for adults with end-stage liver disease. 2. Standards

More information

Adult-to-adult living donor liver transplantation Triumphs and challenges

Adult-to-adult living donor liver transplantation Triumphs and challenges Falk Symposium No. 163 on Chronic Inflammation of Liver and Gut Adult-to-adult living donor liver transplantation Triumphs and challenges ST Fan, MS, MD, PhD, DSc Professor Sun CY Chair of Hepatobiliary

More information

Information for patients (and their families) waiting for liver transplantation

Information for patients (and their families) waiting for liver transplantation Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation

More information

The purpose of donor interchange in living donor

The purpose of donor interchange in living donor Samaritan Case Report donor interchange in LDLT Samaritan donor interchange in living donor liver transplantation See Ching Chan, Kenneth SH Chok, William W Sharr, Albert CY Chan, Simon HY Tsang, Wing

More information

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors? Original Article Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors? R. F. Saidi 1 *, Y. Li 2, S. A. Shah 2, N. Jabbour 2 1 Division of Organ Transplantation, Department

More information

The New England Journal of Medicine. Review Article 16,000 14,000 12,000. No. of Patients 10,000 8,000 6,000 4,000 2,000

The New England Journal of Medicine. Review Article 16,000 14,000 12,000. No. of Patients 10,000 8,000 6,000 4,000 2,000 Review Article Medical Progress ADULT-TO-ADULT TRANSPLANTATION OF THE RIGHT HEPATIC LOBE FROM A LIVING DONOR JAMES F. TROTTER, M.D., MICHAEL WACHS, M.D., GREGORY T. EVERSON, M.D., AND IGAL KAM, M.D. TRANSPLANTATION

More information

Ontario s Referral and Listing Criteria for Adult Kidney Transplantation

Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Version 3.0 Trillium Gift of Life Network Adult Kidney Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The

More information

Surgical management of HCC. Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London

Surgical management of HCC. Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London Surgical management of HCC Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London Global distribution of HCC and staging systems WEST 1. Italy (Milan,

More information

PATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION

PATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION PATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION This policy has been created by the Kidney Advisory Group on behalf of NHSBT. The policy has been considered and approved by the Organ Donation

More information

Evaluation Process for Liver Transplant Candidates

Evaluation Process for Liver Transplant Candidates Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection

More information

Liver transplantation is a gold standard of therapy. Estimation of Standard Liver Volume for Liver Transplantation in the Korean Population

Liver transplantation is a gold standard of therapy. Estimation of Standard Liver Volume for Liver Transplantation in the Korean Population Estimation of Standard Liver Volume for Liver Transplantation in the Korean Population Hee Chul Yu, 1,2 Heecheon You, 3 Ho Lee, 4 Zhe-Wu Jin, 1 Jang Il Moon, 5 and Baik Hwan Cho 1,2 The standard liver

More information

Split Graft Liver Transplant for Paediatric Patients in Hong Kong

Split Graft Liver Transplant for Paediatric Patients in Hong Kong HK J Paediatr (new series) 2009;14:181-185 Split Graft Liver Transplant for Paediatric Patients in Hong Kong PHY CHUNG, KKY WONG, PKH TAM, KL CHAN, KKC NG, SC CHAN, TWC HUI, BH YONG, ST FAN, CM LO Abstract

More information

Liver Transplantation

Liver Transplantation Liver Transplantation Dr Mathew Jacob - MRCS FRCS CCT (UK) Lead Consultant HPB/Transplant Surgeon Aster Integrated Liver Care Program AsterMedcity, kochi, kerala, India mathew@transplantationliver.com

More information

Evaluation Process for Liver Transplant Candidates

Evaluation Process for Liver Transplant Candidates Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection

More information

University of Colorado Health Sciences Center, Denver Colorado ******************** ******************

University of Colorado Health Sciences Center, Denver Colorado ******************** ****************** University of Colorado Health Sciences Center, Denver Colorado ******************** 1988-2005 ****************** Disclosures No disclosures Case 53 M presents with sudden onset of upper abdominal pain

More information

Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation

Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Version 2.0 Trillium Gift of Life Network Adult Pancreas-After-Kidney Transplantation Referral & Listing Criteria

More information

Current State of Living Donor Liver Transplantation

Current State of Living Donor Liver Transplantation REVIEW Current State of Living Donor Liver Transplantation Paige M. Porret, Kim M. Olthoff The discrepancy between the number of patients waiting for a liver and the available number of deceased donors

More information

What Is the Real Gain After Liver Transplantation?

What Is the Real Gain After Liver Transplantation? LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;

More information

THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION

THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION Adopted by the 63rd WMA General Assembly, Bangkok, Thailand, October 2012 PREAMBLE Advances in medical sciences, especially

More information

Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation

Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation Title Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation Author(s) Chan, SC; Fan, ST Citation Hepatobiliary Surgery and Nutrition, 2013, v. 2 n. 2, p.

More information

Patient Education Transplant Services. Glossary of Terms. For a kidney/pancreas transplant

Patient Education Transplant Services. Glossary of Terms. For a kidney/pancreas transplant Patient Education Glossary of Terms For a kidney/pancreas transplant Glossary of Terms Page 18-2 Antibody A protein substance made by the body s immune system in response to a foreign substance. Antibodies

More information

Hong Kong Journal Nephrol of 2000;(2): Nephrology 2000;2(2): BR HAWKINS ORIGINAL A R T I C L E A point score system for allocating cadaver

Hong Kong Journal Nephrol of 2000;(2): Nephrology 2000;2(2): BR HAWKINS ORIGINAL A R T I C L E A point score system for allocating cadaver Hong Kong Journal Nephrol of 2000;(2):79-83. Nephrology 2000;2(2):79-83. ORIGINAL A R T I C L E A point score system for allocating cadaveric kidneys for transplantation based on patient age, waiting time

More information

Variations in Surgical Anatomy of the Portal Vein in Living Donor Liver Transplantation

Variations in Surgical Anatomy of the Portal Vein in Living Donor Liver Transplantation Kasr El Aini Journal of Surgery VOL., 9, NO 3 January 2008 19 Variations in Surgical Anatomy of the Portal Vein in Living Donor Liver Transplantation A. Ayad ; W. Tobar; M.Hassan; A.Hosny; M.El Shazly;

More information

Informed Consent for Liver Transplant Patients

Informed Consent for Liver Transplant Patients Informed Consent for Liver Transplant Patients Evaluation Process You will be evaluated with consultations, lab tests and various procedures to determine the medical appropriateness of liver transplant.

More information

All-in-one sleeve patch graft venoplasty for multiple hepatic vein reconstruction in living donor liver transplantation

All-in-one sleeve patch graft venoplasty for multiple hepatic vein reconstruction in living donor liver transplantation DOI:10.1111/j.1477-2574.2012.00442.x HPB Technical Report All-in-one sleeve patch graft venoplasty for multiple hepatic vein reconstruction in living donor liver transplantation Chao-Long Chen*, Anthony

More information

Overall Goals and Objectives for Transplant Hepatology EPAs:

Overall Goals and Objectives for Transplant Hepatology EPAs: Overall Goals and Objectives for Transplant Hepatology EPAs: 1. DIAGNOSTIC LIST During the one-year Advanced Pediatric Transplant Hepatology Program, fellows are expected to develop comprehensive skills

More information

Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion

Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion Title Author(s) Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion Chan, SC; Fan, ST; Chok, KSH; Cheung, TT; Chan,

More information

Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation

Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Paediatric Referral and Listing Criteria for

More information

Follow-Up of Chinese Liver Transplant Recipients in Hong Kong

Follow-Up of Chinese Liver Transplant Recipients in Hong Kong LIVER TRANSPLANTATION 15:544-550, 2009 ORIGINAL ARTICLE Follow-Up of Chinese Liver Transplant Recipients in Hong Kong Sheung Tat Fan, Haibo Wang, and Banny K. Lam Department of Surgery, The University

More information

Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease

Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Abhi Humar, MD Clinical Director, Thomas E. Starzl Transplantation Institute 1 PITTSBURGH THE BIRTHPLACE OF LIVER TRANSPLANTATION

More information

A Survey of Liver Transplantation from Living Adult Donors in the United States

A Survey of Liver Transplantation from Living Adult Donors in the United States The new england journal of medicine special article A Survey of Liver Transplantation from Living Adult Donors in the United States Robert S. Brown, Jr., M.D., M.P.H., Mark W. Russo, M.D., M.P.H., Michelle

More information

Early Outcome of Donors in Living-Donor Liver Transplantation at King Hussein Medical Center

Early Outcome of Donors in Living-Donor Liver Transplantation at King Hussein Medical Center Early Outcome of Donors in Living-Donor Liver Transplantation at King Hussein Medical Center Salah Halasa MD*, Sahim Qusouss MD* ABSTRACT Objectives: To evaluate the safety and early outcome of donors

More information

2016 Outcomes Report. Liver & Intestinal Transplant Program

2016 Outcomes Report. Liver & Intestinal Transplant Program 2016 Outcomes Report Liver & Intestinal Transplant Program The incredible team at the Stanford Children s Health Transplant Center used an existing procedure in a new way, filtering out the blood cells

More information

Current status of hepatic surgery in Korea

Current status of hepatic surgery in Korea Korean J Hepatol. 2009 Dec; 15(Suppl 6):S60 - S64. DOI: 10.3350/kjhep.2009.15.S6.S60 Current status of hepatic surgery in Korea Kyung Sik Kim Department of Surgery, Severance Hospital, Yonsei University

More information

Laparoscopic Liver Resection for Hepatocellular Carcinoma

Laparoscopic Liver Resection for Hepatocellular Carcinoma Original Article Laparoscopic Liver Resection for Hepatocellular Carcinoma Carmen D. Chung, Lydia L. Lau, Kwan Lung Ko, Andrew C. Wong, Shezam Wong, Albert C. Chan, Ronnie T. Poon, Chung Mau Lo and Sheung

More information

Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation

Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation 8 Original Article Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation Neema Kaseje 1 Samuel Lüthold 2 Gilles Mentha 3 Christian Toso 3 Dominique Belli 2 Valérie McLin 2 Barbara

More information

Living donor liver transplantation without the use of blood products. Liu, CL; Fan, ST; Lo, CM; Wei, WI; Yong, BH; Lai, CL; Wong, J

Living donor liver transplantation without the use of blood products. Liu, CL; Fan, ST; Lo, CM; Wei, WI; Yong, BH; Lai, CL; Wong, J Title Living donor liver transplantation without the use of blood products. Author(s) Liu, CL; Fan, ST; Lo, CM; Wei, WI; Yong, BH; Lai, CL; Wong, J Citation Hong Kong Medical Journal = Xianggang Yi Xue

More information

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Ontario s Adult Referral and Listing Criteria for Liver Transplantation Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL

More information

Living Donor Liver Transplantation

Living Donor Liver Transplantation Patient information Queen Elizabeth Hospital fl/igj Birmingham Part of University Hospitals Birmingham NHS Foundation Trust Birmingham Children's Hospital rliifj NHS Foundation Trust Living Donor Liver

More information

UEMS & EBS: DIVISION OF TRANSPLANT SURGERY

UEMS & EBS: DIVISION OF TRANSPLANT SURGERY CURRICULUM AND SYLLABUS TRANSPLANTATION Module 1: Multi-organ retrieval Ability to evaluate donor suitability Ability to retrieve abdominal organs for transplantation Evaluation of donor/ organs suitability

More information

Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs

Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs LIVER TRANSPLANTATION 14:303-307, 2008 ORIGINAL ARTICLE Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs Kevin P. Charpentier 1 and Arun Mavanur 2 1 Rhode

More information

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017 Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen

More information

Venous Outflow Reconstruction Using an Expanded Polytetrafluoroethylene Vascular Graft in Living-Donor Liver Transplant: A Single-Center Experience

Venous Outflow Reconstruction Using an Expanded Polytetrafluoroethylene Vascular Graft in Living-Donor Liver Transplant: A Single-Center Experience ARTICLe Venous Outflow Reconstruction Using an Expanded Polytetrafluoroethylene Vascular Graft in Living-Donor Liver Transplant: A Single-Center Experience Chia-Yu Lai, 1 Shao-Min Han, 2 Yi-Ju Chen, 1

More information

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Silas P. Norman, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

ORIGINAL ARTICLE. Value of Live Donor Liver Transplantation Experience in Major Hepatectomy for Hepatocellular Carcinoma

ORIGINAL ARTICLE. Value of Live Donor Liver Transplantation Experience in Major Hepatectomy for Hepatocellular Carcinoma ORIGINAL ARTICLE Value of Live Donor Liver Transplantation Eperience in Major Hepatectomy for Hepatocellular Carcinoma See-Ching Chan, FRACDS, FRCS(Edin); Chi-Leung Liu, MS, FRCS(Edin); Chung-Mau Lo, MS,

More information

Liver Transplantation

Liver Transplantation 1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation

More information

Welcome to Transplantation

Welcome to Transplantation Renal Services Welcome to Transplantation Introductory guide to kidney transplantation. Welcome to Transplantation Kidney transplantation is not a cure for your renal disease it is just another form of

More information

Liver transplantation: Hepatocellular carcinoma

Liver transplantation: Hepatocellular carcinoma Liver transplantation: Hepatocellular carcinoma Alejandro Forner BCLC Group. Liver Unit. Hospital Clínic. University of Barcelona 18 de marzo 2015 3r Curso Práctico de Transplante de Órganos Sólidos Barcelona

More information

Living Donor Liver Transplantation NATCO Introductory Course

Living Donor Liver Transplantation NATCO Introductory Course Living Donor Liver Transplantation NATCO Introductory Course Patricia Harren, RN, ANP, MSN, PNP, CCTC New York Presbyterian Medical Center Center for Liver Disease & Transplant New York, NY Living Donor

More information

Management of Hepatitis B - Information for primary care providers

Management of Hepatitis B - Information for primary care providers Management of Hepatitis B - Information for primary care providers July 2018 Chronic hepatitis B (CHB) is often a lifelong condition. Not everyone infected needs anti-viral therapy. This document outlines

More information

Getting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn:

Getting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn: Getting a New Kidney UHN Information for patients and families Read this booklet to learn: about kidney transplants who can be donors how to start the transplant process how long the process might take

More information

Strategies for Widening Liver Donor Pool

Strategies for Widening Liver Donor Pool Review Article Strategies for Widening Liver Donor Pool Ho Yu Chung, See Ching Chan, Chung Mau Lo and Sheung Tat Fan, Department of Surgery, The University of Hong Kong, Hong Kong SAR, China. Liver transplantation

More information

HOW I DO IT Feasibility of Bisegmentectomy 7 8 is Independent of the Presence of a Large Inferior Right Hepatic Vein

HOW I DO IT Feasibility of Bisegmentectomy 7 8 is Independent of the Presence of a Large Inferior Right Hepatic Vein Journal of Surgical Oncology 2006;93:338 342 HOW I DO IT Feasibility of Bisegmentectomy 7 8 is Independent of the Presence of a Large Inferior Right Hepatic Vein MARCEL AUTRAN C. MACHADO, MD, 1,2 * PAULO

More information

Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation

Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation BRIEF REPORT Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation Man-Fung Yuen, 1 Erwin Sablon, 2 Danny Ka-Ho Wong, 1 He-Jun Yuan, 1 Benjamin Chun-Yu Wong, 1 Annie On-On Chan, 1 and

More information

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry American Journal of Transplantation 2016; 16: 688 693 Wiley Periodicals Inc. Brief Communication Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons doi:

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL185/3 Copy Number Effective 02/08/2016 Summary of Significant Changes Inclusion of Simultaneous Islet and Kidney transplants Policy This policy has been created by the Pancreas

More information

Living donor liver transplantation for patients with hepatocellular carcinoma in Japan

Living donor liver transplantation for patients with hepatocellular carcinoma in Japan Sugawara et al. Hepatoma Res 2018;4:33 DOI: 10.20517/2394-5079.2018.69 Hepatoma Research Review Open Access Living donor liver transplantation for patients with hepatocellular carcinoma in Japan Yasuhiko

More information

Organ Procurement and Transplantation Network

Organ Procurement and Transplantation Network OPTN Organ Procurement and Transplantation Network POLICIES This document provides the policy language approved by the OPTN/UNOS Board at its meeting in June 2015 as part of the Operations and Safety Committee

More information

Treatment of HCC in real life-chinese perspective

Treatment of HCC in real life-chinese perspective Treatment of HCC in real life-chinese perspective George Lau MBBS (HK), MRCP(UK), FHKCP, FHKAM (GI), MD(HK), FRCP (Edin, Lond), FAASLD (US) Chairman Humanity and Health Medical Group, Hong Kong SAR, CHINA

More information

Liver Transplantation Evaluation: Objectives

Liver Transplantation Evaluation: Objectives Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation

More information

Resource Document for the Medical Evaluation of Living Kidney Donors

Resource Document for the Medical Evaluation of Living Kidney Donors NOTE: At its September 2007 meeting, the Board of Directors approved only the Introduction and Purpose sections of the proposed resource document. The Board further directed that the resource document

More information

pitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel:

pitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel: 11 687 692 2002 pitfall 1078 29 17 9 1 2 3 dislocation outflow block 11 1 2 3 9 1 2 3 4 disorientation pitfall 11 687 692 2002 Tel: 075-751-3606 606-8507 54 2001 8 27 2002 10 31 29 4 pitfall 16 1078 Table

More information

Ontario s Referral and Listing Criteria for Adult Heart Transplantation

Ontario s Referral and Listing Criteria for Adult Heart Transplantation Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The

More information

Patient Name: MRN: DOB: Treatment Location:

Patient Name: MRN: DOB: Treatment Location: Page 1 of 5 I. TO (Required) This Section is required to be completed by all patients who undergo kidney transplant surgery. I hereby consent to and authorize Dr. and his/her assistant(s), including supervised

More information

Pancreas and Pancreas-Kidney Transplantation By: Kay R. Brown, CLCP

Pancreas and Pancreas-Kidney Transplantation By: Kay R. Brown, CLCP Pancreas and Pancreas-Kidney Transplantation By: Kay R. Brown, CLCP Pancreas transplant recipients are usually under age 50. The majority of pancreas transplants are performed on diabetics, who are generally

More information

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Ronnie T.P. Poon, MBBS, MS, PhD Chair Professor of Hepatobiliary and Pancreatic Surgery Chief of Hepatobiliary and Pancreatic Surgery

More information

An Overview on Attitudes Towards Organ Donation in Hong Kong

An Overview on Attitudes Towards Organ Donation in Hong Kong Original Article An Overview on Attitudes Towards Organ Donation in Hong Kong Beatrice Cheng, Chung-Ping Ho, 1 Shelley Ho, 2 Angela Wong 3 Background: Despite rising patient needs, transplant activities

More information

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which

More information

New Zealand Kidney Allocation Scheme

New Zealand Kidney Allocation Scheme New Zealand Kidney Allocation Scheme The New Zealand Kidney Allocation Scheme (NZKAS) has been developed to ensure that kidney allocation in NZ is performed on an equitable, accountable and transparent

More information

Should the Liver Transplant Criteria for Hepatocellular Carcinoma Be Different for Deceased Donation and Living Donation?

Should the Liver Transplant Criteria for Hepatocellular Carcinoma Be Different for Deceased Donation and Living Donation? LIVER TRANSPLANTATION 17:S133-S138, 2011 SUPPLEMENT Should the Liver Transplant Criteria for Hepatocellular Carcinoma Be Different for Deceased Donation and Living Donation? David Grant, 1,2,5 Robert A.

More information

Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison

Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison ORIGINAL ARTICLE Annals of Gastroenterology (2018) 31, 722-727 Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison Georgios

More information

Information for potential living kidney donors

Information for potential living kidney donors Feedback We appreciate and encourage feedback. If you need advice or are concerned about any aspect of care or treatment please speak to a member of staff or contact the Patient Advice and Liaison Service

More information

Optimal Bile Duct Division Using Real- Time Indocyanine Green Near-Infrared Fluorescence Cholangiography During Laparoscopic Donor Hepatectomy

Optimal Bile Duct Division Using Real- Time Indocyanine Green Near-Infrared Fluorescence Cholangiography During Laparoscopic Donor Hepatectomy LETTERS FROM THE FRONTLINE Optimal Bile Duct Division Using Real- Time Indocyanine Green Near-Infrared Fluorescence Cholangiography During Laparoscopic Donor Hepatectomy TO THE EDITOR: Despite advances

More information

The transplant benefit score and the national liver offering scheme

The transplant benefit score and the national liver offering scheme The transplant benefit score and the national liver offering scheme New national offering scheme The development of a national set of rules to offer livers to named adult patients on the elective liver

More information

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health The New Kidney Allocation System: What You Need to Know Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health ~6% of patients die each year on the deceased donor waiting

More information

Successful Application of Supraceliac Aortohepatic Conduit Using Saphenous Venous Graft in Right Lobe Living Donor Liver Transplantation

Successful Application of Supraceliac Aortohepatic Conduit Using Saphenous Venous Graft in Right Lobe Living Donor Liver Transplantation LETTERS FROM THE FRONTLINE Successful Application of Supraceliac Aortohepatic Conduit Using Saphenous Venous Graft in Right Lobe Living Donor Liver Transplantation TO THE EDITOR: Hepatic artery (HA) reconstruction

More information

Citation Transplantation Proceedings, 47(3),

Citation Transplantation Proceedings, 47(3), NAOSITE: Nagasaki University's Ac Title Author(s) Hybrid Procedure in Living Donor Li Soyama, Akihiko; Takatsuki, Mitsuhi Tomohiko; Kitasato, Amane; Kinoshit Baimakhanov, Zhassulan; Kuroki, Tam Citation

More information

[Submitted Electronically]

[Submitted Electronically] [Submitted Electronically] Dr. Matthew J. Kuehnert, Director Office of Blood, Organ, and Other Tissue Safety Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious

More information

Management of HepatoCellular Carcinoma

Management of HepatoCellular Carcinoma 9th Symposium GIC St Louis - 2010 Management of HepatoCellular Carcinoma Overview Pierre A. Clavien, MD, PhD Department of Surgery University Hospital Zurich Zurich, Switzerland Hepatocellular carcinoma

More information

Living Donor Liver Transplantation Wits Donald Gordon Medical Centre

Living Donor Liver Transplantation Wits Donald Gordon Medical Centre Living Donor Liver Transplantation Wits Donald Gordon Medical Centre J Loveland, J Botha, R Britz, B Strobele, A Mahomed, B Bobat, S Rambarran, F van der Schyff et al The First 1963 C Henry Kempe presented

More information

Chapter 4 Section Combined Heart-Kidney Transplantation (CHKT)

Chapter 4 Section Combined Heart-Kidney Transplantation (CHKT) Surgery Chapter 4 Section 24.3 Issue Date: May 7, 1999 Authority: 32 CFR 199.4(e)(5) 1.0 POLICY 1.1 is a TRICARE benefit that requires preauthorization. 1.1.1 A TRICARE Prime enrollee must have a referral

More information

TA L K I N G A B O U T T R A N S P L A N TAT I O N

TA L K I N G A B O U T T R A N S P L A N TAT I O N TA L K I N G A B O U T T R A N S P L A N TAT I O N Frequently Asked Questions about Kidney Transplant Evaluation and Listing If your kidneys have stopped working properly, or may stop working soon, you

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #400 (NQF 3059): One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY

More information

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC

More information

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC

More information

Liver transplantation is the only hope for patients with terminal. Indication and Prognosis of Liver Transplantation. Abstract

Liver transplantation is the only hope for patients with terminal. Indication and Prognosis of Liver Transplantation. Abstract Indication and Prognosis of Liver Transplantation Jae Won Joh, M.D. Department of General Surgery Sungkyunkwan University School of Medicine Samsung Medical Center E mail: jwjoh@smc.samsung.co.kr Abstract

More information

National liver offering scheme

National liver offering scheme 1 National liver offering scheme Outline 1 Hub Specialist Nurse Organ Donation (SNOD) registers donor with Operations 2 matching Hub Operations initiates the run 3 Hub Matching run offering list printed

More information

Extending Indication: Role of Living Donor Liver Transplantation for Hepatocellular Carcinoma

Extending Indication: Role of Living Donor Liver Transplantation for Hepatocellular Carcinoma LIVER TRANSPLANTATION 13:S48-S54, 27 SUPPLEMENT Extending Indication: Role of Living Donor Liver Transplantation for Hepatocellular Carcinoma Satoru Todo, 1 Hiroyuki Furukawa, 2 Mitsuhiro Tada, 3 and the

More information

Living Donor Liver Transplantation

Living Donor Liver Transplantation Trends in Transplantation Transplant. 2010;4:138-44 Living Donor Liver Transplantation Juan Carlos García-Valdecasas 1, Itxarone Bilbao Aguirre 2, Ramón Charco Torra 3, Constantino Fondevila Campo 4, Josep

More information

Simplifying Hepatic Venous Outflow Reconstruction in Sequential Living Donor Liver Transplantation

Simplifying Hepatic Venous Outflow Reconstruction in Sequential Living Donor Liver Transplantation LIVER TRANSPLANTATION 15:1514-1518, 2009 ORIGINAL ARTICLE Simplifying Hepatic Venous Outflow Reconstruction in Sequential Living Donor Liver Transplantation See Ching Chan, Chung Mau Lo, Kelvin K. Ng,

More information

Transplant Hepatology

Transplant Hepatology Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Case 1 AND. Treatment of HCV: Pre- vs Post- Transplant. 58 yo male, ESRD/diabetic nephropathy, HD for 3 weeks

Case 1 AND. Treatment of HCV: Pre- vs Post- Transplant. 58 yo male, ESRD/diabetic nephropathy, HD for 3 weeks Treatment of HCV: Pre- vs Post- Transplant Roy D. Bloom MD Professor of Medicine University of Pennsylvania Roy D. Bloom MD Professor of Medicine Medical Director, Kidney Transplant Program University

More information

Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST

Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST Title Liver transplantation in mainland China: the overview of CLTR 211 annual scientific report Author(s) Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST Citation Hepatobiliary Surgery and Nutrition,

More information

Your Health Matters. What You Need to Know about Adult Liver Transplantation. Access our patient education library online at

Your Health Matters. What You Need to Know about Adult Liver Transplantation. Access our patient education library online at Access our patient education library online at www.ucsfhealth.org Your Health Matters What You Need to Know about Adult Liver Transplantation Table of Contents 1. Introduction 2. The Preliminary Process

More information

Keeping your options open. Transplant In Center Hemodialysis Home Hemodialysis Peritoneal dialysis No dialysis

Keeping your options open. Transplant In Center Hemodialysis Home Hemodialysis Peritoneal dialysis No dialysis Keeping your options open Transplant In Center Hemodialysis Home Hemodialysis Peritoneal dialysis No dialysis Survival With/Without Transplant % of Transplants 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% Recipient

More information